First-Line Therapy for Metastatic Non–Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches

por Bauml, Joshua, Knepley, Christina
Publicado 2020

Identifying successful biomarkers for patients with non-small-cell lung cancer

por Friedlaender, Alex, Bauml, Joshua, Banna, Giuseppe Luigi, Addeo, Alfredo
Publicado 2019

Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?

por Bauml, Joshua, Chen, Lu, Chen, Jinbo, Boyer, Jean, Kalos, Michael, Li, Susan Q., DeMichele, Angela, Mao, Jun J.
Publicado 2015

Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility Trial

por Bauml, Joshua, Haas, Andrew, Simone, Charles B., Li, Susan Q., Cohen, Roger B., Langer, Corey J., Mao, Jun J.
Publicado 2016

Sex-Related Differences in Outcomes for Oropharyngeal Squamous Cell Carcinoma by HPV Status

por Kao, Derek D., Ferrandino, Rocco M., Marshall, Deborah C., Mutetwa, Tinaye, Miles, Brett, Bauml, Joshua M., Sigel, Keith M.
Publicado 2022

A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy

por Bauml, Joshua, Xie, Sharon X, Penn, Courtney, Desai, Krupali, Dong, Kimberly W, Bruner, Deborah Watkins, Vapiwala, Neha, Mao, Jun James
Publicado 2012

Clinically significant mutations in HIV-infected patients with lung adenocarcinoma

por Thaler, Jonathan, Sigel, Carlie, Beasley, Mary Beth, Wisnivesky, Juan, Crothers, Kristina, Bauml, Joshua, Hysell, Kristen, Emu, Brinda, Borsu, Laetitia, Sigel, Keith
Publicado 2017

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy

por Brady, Anna K., McNeill, Jonathan D., Judy, Brendan, Bauml, Joshua, Evans, Tracey L., Cohen, Roger B., Langer, Corey, Vachani, Anil, Aggarwal, Charu
Publicado 2015

Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018

por Parikh, Ravi B., Robinson, Kyle W., Chhatre, Sumedha, Medvedeva, Elina, Cashy, John P., Veera, Shika, Bauml, Joshua M., Fojo, Tito, Navathe, Amol S., Malkowicz, S. Bruce, Mamtani, Ronac, Jayadevappa, Ravishankar
Publicado 2020

Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic

por Nimgaonkar, Vivek, Aggarwal, Charu, Berman, Abigail T., Gabriel, Peter, Shulman, Lawrence N., Kucharczuk, John, Roy, Megan, Bauml, Joshua M., Singh, Aditi P., Cohen, Roger B., Langer, Corey J., Marmarelis, Melina E.
Publicado 2021

Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real‐world genomic datasets

por Viteri, Santiago, Minchom, Anna, Bazhenova, Lyudmila, Ou, Sai‐Hong Ignatius, Bauml, Joshua M., Shell, Scott A., Schaffer, Michael, Gu, Junchen, Rose, Jennifer B., Curtin, Joshua C., Mahadevia, Parthiv, Girard, Nicolas
Publicado 2022

Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib

por Bauml, Joshua M., Li, Bob T., Velcheti, Vamsidhar, Govindan, Ramaswamy, Curioni-Fontecedro, Alessandra, Dooms, Christophe, Takahashi, Toshiaki, Duda, Andrew W., Odegaard, Justin I., Cruz-Guilloty, Fernando, Jin, Liming, Zhang, Ying, Anderson, Abraham, Skoulidis, Ferdinandos
Publicado 2022

Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): inte...

por Aggarwal, Charu, Cohen, Roger, Morrow, Matthew P, Bauml, Joshua, Weinstein, Gregory, Boyer, Jean, Shen, Xuefei, Yan, Jian, Goldenberg, Jessica, Nashit, Drishty, Oyola, Sandra, Lee, Jessica, Humeau, Laurent M, Weiner, David B, Yang, Zane, Bagarazzi, Mark L, Weiner, David
Publicado 2015

Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy

por Singh, Apurva, Horng, Hannah, Roshkovan, Leonid, Weeks, Joanna K., Hershman, Michelle, Noël, Peter, Luna, José Marcio, Cohen, Eric A., Pantalone, Lauren, Shinohara, Russell T., Bauml, Joshua M., Thompson, Jeffrey C., Aggarwal, Charu, Carpenter, Erica L., Katz, Sharyn I., Kontos, Despina
Publicado 2022

A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer

por Aggarwal, Charu, Maity, Alisha P, Bauml, Joshua M, Long, Qi, Aleman, Tomas, Ciunci, Christine, D’Avella, Christopher, Volpe, Melissa, Anderson, Evan, Jones, Lisa McCormick, Sun, Lova, Singh, Aditi P, Marmarelis, Melina E, Cohen, Roger B, Langer, Corey J, Amaravadi, Ravi
Publicado 2023

Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer

por Sharma, Sonam, Zhou, Olivia, Thompson, Reid, Gabriel, Peter, Chalian, Ara, Rassekh, Christopher, Weinstein, Gregory S., O'Malley, Bert W., Aggarwal, Charu, Bauml, Joshua, Cohen, Roger B., Lukens, J. Nicholas, Swisher-McClure, Samuel, Ghiam, Alireza F., Ahn, Peter H., Lin, Alexander
Publicado 2018

Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurr...

por Aggarwal, Charu, Cohen, Roger B., Morrow, Matthew P., Kraynyak, Kimberly A., Sylvester, Albert J., Cheung, Jocelyn, Dickerson, Kelsie, Schulten, Veronique, Knoblock, Dawson, Gillespie, Elisabeth, Bauml, Joshua M., Yan, Jian, Diehl, Malissa, Boyer, Jean, Dallas, Michael, Kim, J. Joseph, Weiner, David B., Skolnik, Jeffrey M.
Publicado 2020

High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience

por Piper-Vallillo, A.J., Rotow, Julia K., Aredo, Jacqueline V., Shaverdashvili, Khvaramze, Luo, Jia, Carlisle, Jennifer W., Husain, Hatim, Muzikansky, Alona, Heist, Rebecca S., Rangachari, Deepa, Ramalingam, Suresh S., Wakelee, Heather A., Yu, Helena A., Sequist, Lecia V., Bauml, Joshua M., Neal, Joel W., Piotrowska, Zofia
Publicado 2022

Biomarkers predictive of response to pembrolizumab in head and neck cancer

por Pfister, David G., Haddad, Robert I., Worden, Francis P., Weiss, Jared, Mehra, Ranee, Chow, Laura Q. M., Liu, Stephen V., Kang, Hyunseok, Saba, Nabil F., Wirth, Lori J., Sukari, Ammar, Massarelli, Erminia, Ayers, Mark, Albright, Andrew, Webber, Andrea L., Mogg, Robin, Lunceford, Jared, Huang, Lingkang, Cristescu, Razvan, Cheng, Jonathan, Seiwert, Tanguy Y., Bauml, Joshua M.
Publicado 2022

Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study

por Thompson, Jeffrey C., Aggarwal, Charu, Wong, Janeline, Nimgaonkar, Vivek, Hwang, Wei-Ting, Andronov, Michelle, Dibardino, David M., Hutchinson, Christoph T., Ma, Kevin C., Lanfranco, Anthony, Moon, Edmund, Haas, Andrew R., Singh, Aditi P., Ciunci, Christine A., Marmarelis, Melina, D’Avella, Christopher, Cohen, Justine V., Bauml, Joshua M., Cohen, Roger B., Langer, Corey J., Vachani, Anil, Carpenter, Erica L.
Publicado 2022